نتایج جستجو برای: pulmonary thrombo

تعداد نتایج: 226671  

2015
Gabriele Fragasso Angelo Corti Ferdinando Loiacono Alberto Margonato Armando D'Angelo

New oral anticoagulants have been shown to be not inferior to vitamin K antagonists in reducing thrombo-embolic events in patients with non-valvular atrial fibrillation and venous thrombo-embolism. However, those among them whichdirectly inhibit thrombin have been associated with greater risk of myocardial infarction. In this article we review the pleiotropic physiological effects of thrombin a...

2015
MAQBOL UR REHMAN GULSHAN HUSSAIN

OBJECTIVE: To determine the frequency of complications in patients suffering from chronic suppurative otitis media (CSOM). st th METHODS: This study was done in Saidu Sharif Teaching Hospital from 1 March 2010 to 30 June 2013. In this prospective studies 53 patients of Chronic suppurative otitis media were selected. RESULTS: In our study 31(58.4%) male and 22 (41.5%) were female. Age distributi...

Journal: :Medical Microbiology and Immunology 2020

Journal: :Clinical chemistry 1998
R Gambino B L Kasten H W Kaufman J E O'Brien

from peripheral blood leukocytes as described previously (5). Amplification of genomic DNA was performed by PCR as described (1). The G3 A substitution at nucleotide position 20210 was detected by allele-specific restriction digestion by using HindIII (1). Among the 27 patients, 4 (14.8%) were heterozygous for the G 20210 3 A mutation in the prothrombin gene and 1 patient (3.7%) was homozy-gous...

Journal: :Postgraduate medical journal 1964
R NAMBIAR M LENTIN

Two cases of ha-mophilus influenzameningitis have been described who showed lack of response to the routine antibiotics. These two cases did not respond to the oral Penbritin because of vomiting and were treated with intramuscular and intrathecal Penbritin with successful results as shown by biochemical and clinical responses. It should be stressed that neither of these preparations of Penbriti...

Journal: :European heart journal 2007
Peter R Sinnaeve

A percutaneous coronary intervention presents unique challenges to the antithrombotic management of patients requiring chronic anticoagulation. Warfarin is often discontinued several days before a percutaneous intervention, exposing patients to the risk of potentially life-threatening thrombo-embolic complications. In contrast, bridging the period after the intervention until a therapeutic INR ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید